Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Oroxin B
Cat. No.:
OB0225LY-0327
Appearance:
Solid
Purity:
≥98%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
Oroxin B is a compound isolated from medicinal plants with antioxidant and anti-inflammatory activities.
Synonym:
Hypocretin-2; 114482-86-9; Baicalin-7-diglucoside; 5,6-Dihydroxy-2-phenyl-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one
CAS No.:
114482-86-9
Compound CID:
10077207
Formula:
C27H30O15
Formula Weight:
594.52
Specification
Relative Density:
1.76 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Oroxin B can be used in phytochemical studies or play an important role in antioxidant exploration.
Library Information
Targets:
Lipid kinases; Phosphatases; Growth factors; Transcription regulators
Receptors:
PI3K; PTEN; VEGF; p-AKT
Pathways:
Oxidation-reduction; PI3K/Akt/mTOR signaling; Apoptosis; Autophagy
Plate Number:
AOCL-5
Plate Location:
b11
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
55 mg/mL; 92.51 mM
